CoChat

In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [18F]DPA714 PET

Open access
Hagens, Marloes H. J., Golla, Sandeep V., Wijburg, Martijn T., Yaqub, Maqsood, Heijtel, Dennis, Steenwijk, Martijn D., Schober, Patrick, Brevé, John J. P., Schuit, Robert C., Reekie, Tristan A., Kassiou, Michael, van Dam, Anne-Marie, Windhorst, Albert D., Killestein, Joep, Barkhof, Frederik, van Berckel, Bart N. M., Lammertsma, Adriaan A. · 2018 · Journal of Neuroinflammation
Cited by 87

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Over the past decades, positron emission tomography (PET) imaging has become an increasingly useful research modality in the field of multiple sclerosis (MS) research, as PET can visualise molecular processes, such as neuroinflammation, in vivo. The second generation PET radioligand [ 18 F]DPA714 binds with high affinity to the 18-kDa translocator-protein (TSPO), which is mainly expressed on activated microglia. The aim of this proof of concept study was to evaluate this in vivo marker of neuroinflammation in primary and secondary progressive MS. All subjects were genotyped for the rs6971 polymorphism within the TSPO gene, and low-affinity binders were excluded from participation in this study. Eight patients with progressive MS and seven age and genetic binding status matched healthy controls underwent a 60 min dynamic PET scan using [ 18 F]DPA714, including both continuous on-line and manual arterial blood sampling to obtain metabolite-corrected arterial plasma input functions. The optimal model for quantification of [ 18 F]DPA714 kinetics was a reversible two-tissue compartment model with additional blood volume parameter. For genetic high-affinity binders, a clear increase in binding potential was observed in patients with MS compared with age-matched controls. For both high and medium affinity binders, a further increase in binding potential was observed in T2 white matter lesions compared with non-lesional white matter. Volume of distribution, however, did not differentiate patients from healthy controls, as the large non-displaceable compartment of [ 18 F]DPA714 masks its relatively small specific signal. The TSPO radioligand [ 18 F]DPA714 can reliably identify increased focal and diffuse neuroinflammation in progressive MS when using plasma input-derived binding potential, but observed differences were predominantly visible in high-affinity binders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12974-018-1352-9

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 87

Metadata

Authors
Hagens, M. H. J., Golla, S. V., Wijburg, M. T., Yaqub, M., Heijtel, D., Steenwijk, M. D., Schober, P., Brevé, J. J. P., Schuit, R. C., Reekie, T. A., Kassiou, M., van Dam, A.-M., Windhorst, A. D., Killestein, J., Barkhof, F., van Berckel, B. N. M., & Lammertsma, A. A.
Venue
Journal of Neuroinflammation
Published
2018-11-13
Volume
15
Issue
1
Pages
314-314
ISSN
1742-2094 (ISSN-L)
OpenAlex
W2900540791
Cited by
87
References
11
FWCI
8.20
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [18F]DPA714 PET. https://app.cochat.ai/papers/10.1186/s12974-018-1352-9
The paper
Hagens, M. H. J., Golla, S. V., Wijburg, M. T., Yaqub, M., Heijtel, D., Steenwijk, M. D., Schober, P., Brevé, J. J. P., Schuit, R. C., Reekie, T. A., Kassiou, M., van Dam, A.-M., Windhorst, A. D., Killestein, J., Barkhof, F., van Berckel, B. N. M., & Lammertsma, A. A. (2018). In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [18F]DPA714 PET. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-018-1352-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.